Apixaban reduces clot risk in dialysis patients after vascular procedure: Study

A recent study from National Taiwan University Hospital shows that apixaban, a blood-thinning medication, can help prevent blood clots in dialysis patients after a procedure to clear blocked vascular access. Dialysis patients rely on vascular access—like fistulas or grafts—to filter their blood, but clots can form and block these pathways, making dialysis impossible.

Understanding older care leavers’ perceptions and experiences of aged care services

A new National Center for Healthy Aging-led review, in partnership with Monash University, has explored key issues facing the more than 500,000 older care leavers who are transitioning into the aged care support system, underscoring the importance of incorporating the voices and diverse experiences of care leavers into research to inform policy and practice.

Rise in kidney disease underscores critical heart–kidney connection

Globally, the rate of death from chronic kidney disease increased 24% from 1990 to 2021, according to statistics published by the American Heart Association. The rise in kidney disease rates is a major concern for cardiovascular health around the world. Kidney disease increases heart disease risk, yet as many as 9 in 10 U.S. adults with chronic kidney disease do not know they have it.